Related Experiment Video
Updated: Feb 5, 2026

Determining the Phagocytic Activity of Clinical Antibody Samples
Published on: November 30, 2011
Antinuclear antibodies in healthy people and non-rheumatic diseases - diagnostic and clinical implications
Bogna Grygiel-Górniak1, Natalia Rogacka1, Mariusz Puszczewicz1
1Department of Rheumatology and Internal Medicine, Poznań University of Medical Sciences, Poland.
Abstract:
The presence of antinuclear antibodies (ANA) is mainly associated with connective tissue diseases (CTD). In addition, their presence is found in healthy people. These antibodies are more common in women and the elderly. Some drugs and xenobiotics are also important for the development of autoimmunity and ANA synthesis. Moreover, the deficiency of vitamin D in the body of patients correlates with occurrence of these antibodies. Unlike the healthy group, a positive ANA count was observed in patients with atopic dermatitis (AD) and in people with immune disorders. Antinuclear antibodies in low counts are also found in the course of chronic bacterial or viral infection and in patients with hematological malignancies. Also the possibility of false positive results, which may be caused by the choice of method used to determine antibodies, should be borne in mind. Taking into account all these factors, it is concluded that the ANA result itself has no diagnostic value.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Rheumatic Heart Disease I: Introduction
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease III: Medical Management

